SpringWorks Therapeutics, Inc. SWTX was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the stock is now up 25.7% in the past one-month time frame.
The company has seen two positive estimate revisions in the past few months, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few months, suggesting that more solid trading could be ahead for SpringWorks Therapeutics. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
SpringWorks Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
SpringWorks Therapeutics Inc. Price
SpringWorks Therapeutics Inc. price | SpringWorks Therapeutics Inc. Quote
A better-ranked stock in the Medical - Biomedical and Genetics industry is Akcea Therapeutics, Inc. AKCA, which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Hottest Tech Mega-Trend of All
Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Akcea Therapeutics, Inc. (AKCA) : Free Stock Analysis Report
SpringWorks Therapeutics Inc. (SWTX) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research